Financial woes hit data analytics firm amid controversial practices
MultiPlan, a key player in the health insurance industry credited with helping major insurers save billions through minimized medical reimbursements, is currently going through a tumultuous period of increased regulatory and financial scrutiny. The New York-based company, which influences more than 100,000 health plans covering more than 60 million people, has come under fire for practices that could leave patients with large medical bills. Recent investigations have shed a harsh light on MultiPlan’s marketing tactics, which often result in insurers paying health care providers significantly less than they are charged. This strategy, while financially advantageous for insurers and MultiPlan, often…
